RPC Gap Production and Performance for CMS RE4 Upgrade

CMS experiment constructed the fourth Resistive Plate Chamber (RPC) trigger station composed of 144 RPCs to enhance the high momentum muon trigger efficiency at both endcap regions. All new CMS endcap RPC gaps are produced in accordance with QA and QC at the Korea Detector Laboratory (KODEL) in Korea. All qualified gaps have been delivered to three assembly sites: CERN in Switzerland, BARC in India, and Ghent University in Belgium for the RPC detector assembly. In this paper, we present the detailed procedures used in the production of RPC gaps adopted for the CMS upgrade.Comment: RPC2014 conference contribution, 7 pages, 8 figure

Difference in the color stability of direct and indirect resin composites

Indirect resin composites are generally regarded to have better color stability than direct resin composites since they possess higher conversion degree. OBJECTIVE: The present study aimed at comparing the changes in color (ΔE) and color coordinates (ΔL, Δa and Δb) of one direct (Estelite Sigma: 16 shades) and 2 indirect resin composites (BelleGlass NG: 16 shades; Sinfony: 26 shades) after thermocycling. MATERIAL AND METHODS: Resins were packed into a mold and light cured; post-curing was performed on indirect resins. Changes in color and color coordinates of 1-mm-thick specimens were determined after 5,000 cycles of thermocycling on a spectrophotometer. RESULTS: ΔE values were in the range of 0.3 to 1.2 units for direct resins, and 0.3 to 1.5 units for indirect resins, which were clinically acceptable (Δ

Influence of HEMA content on the mechanical and bonding properties of experimental HEMA-added glass ionomer cements

The purpose of this study was to determine the influence of incrementally added uncured HEMA in experimental HEMA-added glass ionomer cement (HAGICs) on the mechanical and shear bond strength (SBS) of these materials. Increasing contents of uncured HEMA (10-50 wt.%) were added to a commercial glass ionomer cement liquid (Fuji II, GC, Japan), and the compressive and diametral tensile strengths of the resulting HAGICs were measured. The SBS to non-precious alloy, precious alloy, enamel and dentin was also determined after these surfaces were subjected to either airborne-particle abrasion (Aa) or SiC abrasive paper grinding (Sp). Both strength properties of the HAGICs first increased and then decreased as the HEMA content increased, with a maximum value obtained when the HEMA content was 20% for the compressive strength and 40% for the tensile strength. The SBS was influenced by the HEMA content, the surface treatment, and the type of bonding surface (

Differences in the Tongue Features of Primary Dysmenorrhea Patients and Controls over a Normal Menstrual Cycle

Background. The aims of this study were to investigate the relationships between tongue features and the existence of menstrual pain and to provide basic information regarding the changes in tongue features during a menstrual cycle. Methods. This study was conducted at the Kyung Hee University Medical Center. Forty-eight eligible participants aged 20 to 29 years were enrolled and assigned to two groups according to their visual analogue scale (VAS) scores. Group A included 24 females suffering from primary dysmenorrhea (PD) caused by qi stagnation and blood stasis syndrome with VAS ≥ 4. In contrast, Group B included 24 females with few premenstrual symptoms and VAS < 4. All participants completed four visits (menses-follicular-luteal-menses phases), and the tongue images were taken by using a computerized tongue image analysis system (CTIS). Results. The results revealed that the tongue coating color value and the tongue coating thickness in the PD group during the menstrual phase were significantly lower than those of the control group (P=0.031 and P=0.029, resp.). Conclusions. These results suggest that the tongue features obtained from the CTIS may serve as a supplementary means for the differentiation of syndromes and the evaluation of therapeutic effect and prognosis in PD. Trial Registration. This trial was registered with Clinical Research Information Service, registration number KCT0001604, registered on 27 August 2015